Missing Links? Citation Matrix | Graphs | Glossary HistCite Guide About |
MELLIN GW, 1962, NEW ENGL J MED, V267, P1184 MELLIN GW, 1962, NEW ENGL J MED, V267, P1238 LENZ W, 1961, DEUT MED WOCHENSCHR, V86, P2555 LENZ W, 1962, DEUT MED WOCHENSCHR, V87, P1232 KUNZ W, 1956, ARZNEIMITTEL-FORSCH, V6, P426 SHESKIN J, 1965, LEPROSY REV, V36, P183 WIEDEMANN HR, 1961, MED WELT, V37, P1863 BECKMANN R, 1962, ARZNEIMITTEL-FORSCH, V12, P1095 |
Nodes: 2685,
Authors: 6203,
Journals: 662,
Outer References: 16023,
Words: 3995
Collection span: 1956 - 2004
View: Overview. Sorted by journal name.
Page 5: 1 2 3 4 5 6 7 8 9
# | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
---|---|---|---|---|---|
1201 | 20 | 39 | 780 1982 DERMATOLOGICA 165(4):355-362 SCOLARI F; HARMS M; GILARDI S THALIDOMIDE IN THE TREATMENT OF CHRONIC LUPUS-ERYTHEMATOSUS | 7 | 9 |
1202 | 3 | 17 | 850 1984 DERMATOLOGICA 168(4):182-188 GENVO MF; FAURE M; THIVOLET J THALIDOMIDE AND THALIDOMIDE WITH COLCHICINE IN THE TREATMENT OF APHTHOSIS, RECURRENT MUCOCUTANEOUS APHTHAE AND BEHCETS-DISEASE | 8 | 16 |
1203 | 4 | 5 | 967 1988 DERMATOLOGICA 176(2):107-107 VIRABEN R; DUPRE A ERYTHEMA-NODOSUM FOLLOWING THALIDOMIDE THERAPY FOR BEHCET DISEASE | 1 | 5 |
1204 | 18 | 22 | 1138 1994 DERMATOLOGY 189(2):179-181 BIELSA I; TEIXIDO J; RIBERA M; FERRANDIZ C ERYTHRODERMA DUE TO THALIDOMIDE - REPORT OF 2 CASES | 13 | 17 |
1205 | 8 | 9 | 1257 1996 DERMATOLOGY 193(4):321-323 Bonnetblanc JM; Royer C; Bedane C Thalidomide and recurrent aphthous stomatitis: A follow-up study | 5 | 10 |
1206 | 2 | 8 | 1333 1997 DERMATOLOGY 195(4):359-361 Ferrandiz C; Carrascosa JM; Just M; Bielsa I; Ribera M Sequential combined therapy with thalidomide and narrow-band (TLO1) UVB in the treatment of prurigo nodularis | 9 | 11 |
1207 | 2 | 5 | 1534 1999 DERMATOLOGY 199(2):195-195 Bez C; Lodi G; Sardella A; Della Volpe A; Carrassi A Oral lichenoid lesions after thalidomide treatment | 5 | 5 |
1208 | 11 | 26 | 2171 2002 DERMATOLOGY 204(4):365-367 Nijsten T; Meuleman L; Schroyens W; Lambert J Thalidomide-induced morbilliform rash: Diagnosis and continuation of therapy, premedicated with methylprednisolone | 0 | 0 |
1209 | 11 | 18 | 2446 2003 DERMATOLOGY 206(4):381-383 Kolivras A; De Maubeuge J; Andre J; Song M Thalidomide in refractory vulvar ulcerations associated with Crohn's disease | 1 | 1 |
1210 | 12 | 17 | 2615 2004 DERMATOLOGY 208(2):149-152 Sander CS; Kaatz M; Elsner P Successful treatment of cutaneous Langerhans cell histiocytosis with thalidomide | 0 | 0 |
# | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
1211 | 0 | 0 | 41 1961 DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT 86(52):2555-& LENZ W KINDLICHE MISSBILDUNGEN NACH MEDIKAMENT-EINNAHME WAHREND DER GRAVIDITAT | 60 | 144 |
1212 | 5 | 15 | 97 1962 DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT 87(24):1232-& LENZ W; KNAPP K DIE THALIDOMID-EMBRYOPATHIE | 48 | 144 |
1213 | 1 | 8 | 374 1966 DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT 91(24):1132-& LENZ W CAN THALIDOMIDE SUPPRESS IMMUNOLOGICAL REACTIONS | 2 | 2 |
1214 | 4 | 8 | 430 1967 DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT 92(47):2186-& LENZ W SENSITIVE PHASE OF THALIDOMIDE EMBRYOPATHIES IN MONKEYS AND MEN | 0 | 1 |
1215 | 0 | 0 | 943 1987 DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT 112(9):365-365 LENZ W THALIDOMIDE-CAUSED BIRTH-DEFECTS | 0 | 0 |
1216 | 0 | 16 | 1008 1990 DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT 115(25):977-979 BROCHELER J; HALFMANN R ANTERIOR SACRAL MENINGOCELE ASSOCIATED WITH THALIDOMIDE EMBRYOPATHY | 0 | 0 |
1217 | 0 | 0 | 1702 2000 DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT 125:S26-S27 Eichhorn A; Kirch W Thalidomide for Behcets syndrome | 0 | 0 |
1218 | 36 | 49 | 1914 2001 DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT 126(42):1178-1182 Tuinmann G; Hegewisch-Becker S; Hossfeld DK New indications for thalidomide | 2 | 3 |
1219 | 4 | 26 | 1915 2001 DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT 126(42):1183-1186 Maio G On the history of the Contergan (thalidomide) catastrophe in the light of drug legislation | 0 | 3 |
1220 | 6 | 6 | 2172 2002 DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT 127(15):818-818 Mensing H New indication for thalidomide? | 0 | 0 |
# | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
1221 | 5 | 10 | 781 1982 DEVELOPMENT GROWTH & DIFFERENTIATION 24(2):217-222 MCBRIDE WG; STOKES PA; VARDY PH MATERNAL THALIDOMIDE TREATMENT AND CELL-DIVISION IN CULTURED RABBIT EMBRYOS - AUTOMATED IMAGE-ANALYSIS OF AUTORADIOGRAPHS | 2 | 2 |
1222 | 13 | 34 | 818 1983 DEVELOPMENT GROWTH & DIFFERENTIATION 25(4):361-373 MCBRIDE WG; VARDY PH PATHOGENESIS OF THALIDOMIDE TERATOGENESIS IN THE MARMOSET (CALLITHRIX-JACCHUS) - EVIDENCE SUGGESTING A POSSIBLE TROPHIC INFLUENCE OF CHOLINERGIC NERVES IN LIMB MORPHOGENESIS | 1 | 6 |
1223 | 23 | 39 | 1258 1996 DEVELOPMENT GROWTH & DIFFERENTIATION 38(1):47-57 Audit CO; Eger K; Aimar C Possible involvement of an acylation mechanism in thalidomide-induced teratogenesis of the newt (Pleurodeles waltl) | 2 | 2 |
1224 | 5 | 24 | 550 1972 DEVELOPMENTAL BIOLOGY 28(1):61-& LASH JW; SAXEN L HUMAN TERATOGENESIS - IN-VITRO STUDIES ON THALIDOMIDE-INHIBITED CHONDROGENESIS | 9 | 26 |
1225 | 0 | 0 | 1703 2000 DEVELOPMENTAL DYNAMICS 219(3):443-443 Fillmore BJ; Stephens TD Angiogenic integrin avb3 as a site of the teratogenic action of thalidomide | 0 | 0 |
1226 | 6 | 38 | 2173 2002 DEVELOPMENTAL DYNAMICS 225(2):186-194 Hansen JM; Gong SG; Philbert M; Harris C Misregulation of gene expression in the redox-sensitive NF-kappa B-dependent limb outgrowth pathway by thalidomide | 1 | 2 |
1227 | 9 | 25 | 375 1966 DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY 8(6):761-& GORDON G MECHANISM OF THALIDOMIDE DEFORMITIES CORRELATED WITH PATHOGENIC EFFECTS OF PROLONGED DOSAGE IN ADULTS | 5 | 5 |
1228 | 13 | 41 | 431 1967 DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY 9(1):87-& METCALF WK RELATION OF VITAMIN-B COMPLEX TO EFFECT OF THALIDOMIDE ON SENSITIVITY OF INTRACELLULAR HAEMOGLOBIN TO OXIDATION | 0 | 1 |
1229 | 0 | 0 | 432 1967 DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY 9(6):707-& DAVIGNON M; HELLGREN K; JUHLIN IM; ATTERBAC.B DIAGNOSTIC AND HABILITATION PROBLEMS OF THALIDOMIDE-TRAUMATIZED CHILDREN WITH MULTIPLE HANDICAPS | 2 | 2 |
1230 | 1 | 8 | 482 1969 DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY 11(6):743-& SIMARD TG; LADD HW CONSCIOUS CONTROL OF MOTOR UNITS WITH THALIDOMIDE CHILDREN - AN ELECTROMYOGRAPHIC STUDY | 0 | 4 |
# | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
1231 | 0 | 9 | 566 1973 DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY 15(6):719-727 MCFIE J; ROBERTSO.J PSYCHOLOGICAL TEST RESULTS OF CHILDREN WITH THALIDOMIDE DEFORMITIES | 1 | 8 |
1232 | 11 | 28 | 620 1976 DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY 18(2):189-197 STEPHENSON JBP EPILEPSY - NEUROLOGICAL COMPLICATION OF THALIDOMIDE EMBRYOPATHY | 7 | 11 |
1233 | 7 | 19 | 1139 1994 DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY 36(4):351-356 STROMLAND K; NORDIN V; MILLER M; AKERSTROM B; GILLBERG C AUTISM IN THALIDOMIDE EMBRYOPATHY - A POPULATION STUDY | 3 | 71 |
1234 | 0 | 0 | 1704 2000 DIABETES 49:A434-A434 Iqbal N; Boden G Thalidomide impairs insulin stimulated glucose uptake in patients with type 2 diabetes (T2DM) by inhibiting glycogen synthesis | 0 | 0 |
1235 | 0 | 0 | 1916 2001 DIABETES 50:A473-A473 Bosco A; Lerario AC; Santos RF; Ferreira A; Ursich MJ; Silva ME; Rocha DM; Wajchenberg BL Study of Thalidomide and Rosiglitazone effects on the prevention of diabetic retinopathy of Streptozotocin diabetic rats | 0 | 0 |
1236 | 7 | 23 | 1705 2000 DIABETES CARE 23(8):1172-1176 Iqbal N; Zayed M; Boden G Thalidomide impairs insulin action on glucose uptake and glycogen synthesis in patients with type 2 diabetes | 3 | 3 |
1237 | 2 | 3 | 2447 2003 DIABETES CARE 26(4):1322-1323 Pathak RD; Jayaraj K; Blonde L Thalidomide-associated hyperglycemia and diabetes - Case report and review of literature | 0 | 0 |
1238 | 6 | 42 | 2448 2003 DIABETOLOGIA 46(12):1669-1675 Bosco AA; Lerario AC; Santos RF; Wajchenberg BL Effect of thalidomide and rosiglitazone on the prevention of diabetic retinopathy in streptozotocin-induced diabetic rats | 1 | 1 |
1239 | 1 | 1 | 2616 2004 DIABETOLOGIA 47(5):963-963 Bosco AA; Lerario AC; Santos RF; Wajchenberg BL Effect of thalidomide and rosiglitazone on the prevention of diabetic retinopathy in streptozotocin-induced diabetic rats (vol 46, pg 1669, 2003) | 0 | 0 |
1240 | 2 | 7 | 1009 1990 DICP-THE ANNALS OF PHARMACOTHERAPY 24(5):482-483 JEW LJ; MIDDLETON RK THALIDOMIDE IN ERYTHEMA-NODOSUM LEPROSUM | 0 | 0 |
# | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
1241 | 6 | 13 | 1010 1990 DICP-THE ANNALS OF PHARMACOTHERAPY 24(11):1054-1056 NICOLAU DP; WEST TE THALIDOMIDE - TREATMENT OF SEVERE RECURRENT APHTHOUS STOMATITIS IN PATIENTS WITH AIDS | 9 | 17 |
1242 | 5 | 10 | 1187 1995 DIGESTIVE DISEASES AND SCIENCES 40(5):1147-1148 NAUM SM; MOLLOY PJ; KANIA RJ; MCGARR J; VANTHIEL DH USE OF THALIDOMIDE IN TREATMENT AND MAINTENANCE OF IDIOPATHIC ESOPHAGEAL ULCERS IN HIV+ INDIVIDUALS | 7 | 11 |
1243 | 2 | 14 | 42 1961 DISEASES OF THE NERVOUS SYSTEM 22(1):52-& NEUHAUS G; IBE K SURVIVAL FOLLOWING OVERDOSE OF THALIDOMIDE | 5 | 7 |
1244 | 0 | 0 | 567 1973 DRUG & COSMETIC INDUSTRY 113(3):35-& DAVIS DA GREATEST TRAGEDY - THALIDOMIDE TOLL CLEARER NOW | 0 | 0 |
1245 | 18 | 63 | 1917 2001 DRUG DEVELOPMENT RESEARCH 54(4):209-218 Fernandez-Martinez E; Morales-Rios MS; Perez-Alvarez V; Muriel P Effects of thalidomide and 3-phthalimido-3-(3,4-dimethoxyphenyl)-propanamide on bile duct obstruction-induced cirrhosis in the rat | 1 | 2 |
1246 | 18 | 24 | 993 1989 DRUG METABOLISM AND DISPOSITION 17(4):402-405 CHEN TL; VOGELSANG GB; PETTY BG; BRUNDRETT RB; NOE DA; SANTOS GW; COLVIN OM PLASMA PHARMACOKINETICS AND URINARY-EXCRETION OF THALIDOMIDE AFTER ORAL DOSING IN HEALTHY MALE-VOLUNTEERS | 77 | 81 |
1247 | 8 | 13 | 1918 2001 DRUG METABOLISM AND DISPOSITION 29(10):1355-1357 Teo SK; Harden JL; Burke AB; Noormohamed FH; Youle M; Johnson MA; Peters BS; Stirling DI; Thomas SD Thalidomide is distributed into human semen after oral dosing | 7 | 12 |
1248 | 21 | 37 | 2449 2003 DRUG METABOLISM AND DISPOSITION 31(4):469-475 Miyata M; Tamura E; Motoki K; Nagata K; Yamazoe Y Thalidomide-induced suppression of embryo fibroblast proliferation requires CYP1A1-mediated activation | 2 | 2 |
1249 | 0 | 0 | 2450 2003 DRUG METABOLISM AND DISPOSITION 31(8):1072-1072 Miyata M CYP1A1-mediated activation of thalidomide and suppression of embryo fibroblast proliferation - Reply | 0 | 0 |
1250 | 5 | 10 | 2451 2003 DRUG METABOLISM AND DISPOSITION 31(8):1072-1072 Zhou SF CYP1A1-mediated activation of thalidomide and suppression of embryo fibroblast proliferation | 0 | 0 |
# | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
1251 | 0 | 0 | 2174 2002 DRUG METABOLISM REVIEWS 34:148-148 Zhou SF; Li Y; Kestell P; Paxton JW Preliminary study of thalidomide transport by the human intestinal cell line Caco-2 | 0 | 0 |
1252 | 0 | 0 | 1334 1997 DRUG NEWS & PERSPECTIVES 10(8):506-506 [Anon] Celgene's thalidomide approvable for ENL | 0 | 0 |
1253 | 0 | 0 | 1706 2000 DRUG NEWS & PERSPECTIVES 13(3):146-146 [Anon] Celgene's IMiDS and thalidomide show activity as COX-2 inhibitors | 1 | 0 |
1254 | 17 | 34 | 2175 2002 DRUG NEWS & PERSPECTIVES 15(9):604-611 Botting J The history of thalidomide | 0 | 1 |
1255 | 0 | 0 | 1056 1992 DRUG SAFETY 7(2):116-134 GUNZLER V THALIDOMIDE IN HUMAN-IMMUNODEFICIENCY-VIRUS (HIV) PATIENTS - A REVIEW OF SAFETY CONSIDERATIONS | 59 | 75 |
1256 | 0 | 0 | 1188 1995 DRUG SAFETY 12(6):364-369 SCHULER U; EHNINGER G THALIDOMIDE - RATIONALE FOR RENEWED USE IN IMMUNOLOGICAL DISORDERS | 25 | 36 |
1257 | 9 | 10 | 1431 1998 DRUG SAFETY 19(5):339-341 Smithells D Does thalidomide cause second generation birth defects? | 4 | 4 |
1258 | 15 | 23 | 1535 1999 DRUG SAFETY 21(3):161-169 Lary JM; Daniel KL; Erickson JD; Roberts HE; Moore CA The return of thalidomide - Can birth defects be prevented? | 5 | 10 |
1259 | 53 | 140 | 1919 2001 DRUG SAFETY 24(2):87-117 Clark TE; Edom N; Larson J; Lindsey LJ Thalomid (R) (Thalidomide) capsules - A review of the first 18 months of spontaneous postmarketing adverse event surveillance, including off-label prescribing | 11 | 13 |
1260 | 12 | 70 | 1536 1999 DRUGS 58(6):953-963 Ravot E; Lisziewicz J; Lori F New uses for old drugs in HIV infection - The role of hydroxyurea, cyclosporin and thalidomide | 3 | 15 |
# | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
1261 | 54 | 120 | 1707 2000 DRUGS 60(2):273-292 Peuckmann V; Fisch M; Bruera E Potential novel uses of thalidomide - Focus on palliative care | 27 | 40 |
1262 | 47 | 67 | 1920 2001 DRUGS 61(6):777-787 Bousvaros A; Mueller B Thalidomide in gastrointestinal disorders | 4 | 8 |
1263 | 110 | 164 | 2176 2002 DRUGS & AGING 19(2):85-100 Zhou SF; Kestell P; Tingle MD; Paxton JW Thalidomide in cancer treatment - A potential role in the elderly? | 4 | 5 |
1264 | 16 | 47 | 1921 2001 DRUGS OF THE FUTURE 26(1):100-103 [Anon] Thalidomide - Synovir (R) - Thalomid (R) - Talizer (R) - Oncolytic treatment of IBD antiarthritic treatment of leprosy | 0 | 0 |
1265 | 8 | 28 | 2617 2004 DRUGS OF THE FUTURE 29(4):383-391 Hashimoto Y; Tanatani A; Nagasawa K; Miyachi H Thalidomide as a multitarget drug and its application as a template for drug design | 0 | 0 |
1266 | 24 | 52 | 2618 2004 DRUGS OF TODAY 40(3):197-204 Joglekar S; Levin M The promise of thalidomide: Evolving indications | 0 | 0 |
1267 | 0 | 0 | 98 1962 ECONOMIST 204(8):711-712 [Anon] AFTER THALIDOMIDE | 0 | 0 |
1268 | 0 | 0 | 99 1962 ECONOMIST 204(9):769-769 SWEETMAN WP AFTER THALIDOMIDE | 0 | 0 |
1269 | 0 | 0 | 782 1982 EEG-EMG-ZEITSCHRIFT FUR ELEKTROENZEPHALOGRAPHIE ELEKTROMYOGRAPHIE UND VERWANDTE GEBIETE 13(4):167-170 LUDOLPH A; MATZ DR ELECTRONEUROGRAPHIC STUDIES IN PATIENTS UNDER THALIDOMIDE THERAPY OF LUPUS ERYTHEMATODES DISCOIDES | 6 | 1 |
1270 | 0 | 0 | 376 1966 ELECTROENCEPHALOGRAPHY AND CLINICAL NEUROPHYSIOLOGY 21(2):201-& PAMPIGLI.G; QUIBELL EP EEG STUDIES IN SO-CALLED THALIDOMIDE BABIES | 0 | 1 |
# | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
1271 | 0 | 0 | 433 1967 ELECTROENCEPHALOGRAPHY AND CLINICAL NEUROPHYSIOLOGY 22(2):193-& HORSTMAN.W EEG FINDINGS IN THALIDOMIDE-DAMAGED CHILDREN | 0 | 0 |
1272 | 0 | 0 | 725 1980 ELECTROENCEPHALOGRAPHY AND CLINICAL NEUROPHYSIOLOGY 50(1-2):P25-P25 HANADA K; KANNO O; KAZAMATSURI H; ASAKA A ELECTROENCEPHALOGRAPHY IN PATIENTS WITH THALIDOMIDE EMBRYOPATHY | 0 | 0 |
1273 | 0 | 0 | 749 1981 ELECTROENCEPHALOGRAPHY AND CLINICAL NEUROPHYSIOLOGY 52(3):S7-S7 LIPINSKI CG; WEISSER J PATHOLOGICAL EEG FINDINGS IN ADOLESCENTS WITH SEVERE SEQUELAE AFTER THALIDOMIDE EMBRYOPATHY | 0 | 0 |
1274 | 0 | 0 | 819 1983 ELECTROENCEPHALOGRAPHY AND CLINICAL NEUROPHYSIOLOGY 56(3):S128-S128 LUDOLPH A; SCHULTE J; BRUNE GG ELECTRO-PHYSIOLOGICAL STUDIES CONCERNING THE REVERSIBILITY OF POLYNEUROPATHIES DUE TO THALIDOMIDE THERAPY OF LUPUS ERYTHEMATODES DISCOIDES | 0 | 0 |
1275 | 0 | 0 | 882 1985 ELECTROENCEPHALOGRAPHY AND CLINICAL NEUROPHYSIOLOGY 61(3):S174-S174 KANNO O; KAZAMATSURI H ELECTROENCEPHALOGRAPHIC STUDY ON THALIDOMIDE EMBRYOPATHY | 0 | 0 |
1276 | 2 | 2 | 920 1986 ELECTROENCEPHALOGRAPHY AND CLINICAL NEUROPHYSIOLOGY 64(3):P66-P66 SMITH NJ; JENKINS JS; POWELL RJ; ALLEN BR; LITTLEWOOD SM; MAURICE PDL NERVE-CONDUCTION STUDIES IN PATIENTS TAKING THALIDOMIDE | 0 | 0 |
1277 | 13 | 34 | 1537 1999 ELECTROPHORESIS 20(12):2425-2431 Meyring M; Chankvetadze B; Blaschke G Enantioseparation of thalidomide and its hydroxylated metabolites using capillary electrophoresis with various cyclodextrins and their combinations as chiral buffer additives | 2 | 13 |
1278 | 17 | 32 | 1708 2000 ELECTROPHORESIS 21(15):3270-3279 Meyring M; Muhlenbrock C; Blaschke G Investigation of the stereoselective in vitro biotransformation of thalidomide using a dual cyclodextrin system in capillary electrophoresis | 7 | 16 |
1279 | 10 | 46 | 1922 2001 ELECTROPHORESIS 22(15):3185-3190 Schoetz G; Trapp O; Schurig V Determination of the enantiomerization barrier of thalidomide by dynamic capillary electrokinetic chromatography | 1 | 4 |
1280 | 1 | 5 | 1259 1996 ENDOSCOPY 28(5):471-472 Louvel D; Musso S; Metivier S; Croizet O; Rouquet RM; Massip P; Escourrou J; Frexinos J Idiopathic esophageal ulceration associated with human immunodeficiency virus infection: Efficacy of thalidomide treatment | 0 | 1 |
# | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
1281 | 0 | 4 | 519 1971 ENGINEERING MATERIALS AND DESIGN 14(6):588-& RING ND; BENFORD JM CARBON FIBRE AIDS THALIDOMIDE CHILDREN | 0 | 0 |
1282 | 0 | 0 | 520 1971 ENVIRONMENT 13(10):50-& DOUGHERT.RC THALIDOMIDE | 0 | 0 |
1283 | 0 | 0 | 1189 1995 ENVIRONMENTAL HEALTH PERSPECTIVES 103(2):132-132 [Anon] RETHINKING THALIDOMIDE | 0 | 0 |
1284 | 20 | 36 | 1538 1999 ETHIOPIAN MEDICAL JOURNAL 37(4):275-280 Shannon EJ 24th Kellersberger Memorial Lecture, 1999 thalidomide: Will the past overshadow a promising future? | 0 | 0 |
1285 | 10 | 23 | 100 1962 EUGENICS QUARTERLY 9(2):95-& JARVIK LF CONGENITAL MALFORMATIONS ATTRIBUTED TO SLEEPING PILL (THALIDOMIDE) | 0 | 1 |
1286 | 0 | 0 | 1190 1995 EUROPEAN CHEMICAL NEWS 63(1667):8-8 [Anon] GUINNESS TOPS UP THALIDOMIDE FUND | 0 | 0 |
1287 | 0 | 0 | 1335 1997 EUROPEAN CHEMICAL NEWS 68(1780):51-51 [Anon] Celgene - FDA approves thalidomide's use against ENL | 0 | 0 |
1288 | 0 | 0 | 1432 1998 EUROPEAN CYTOKINE NETWORK 9(3):367-367 Corral LG; Haslett PAJ; Ocampo C; Muller GW; Wong ML; Stirling D; Kaplan G Two distinct classes of thalidomide analogues which shape potent TNF-alpha inhibitory activity, modulate other cytokines differently | 0 | 0 |
1289 | 7 | 20 | 1709 2000 EUROPEAN CYTOKINE NETWORK 11(4):574-579 van Crevel R; Vonk AG; Netea MG; Kullberg BJ; van der Meer JWM Modulation of LPS-, PHA-and M-tuberculosis-mediated cytokine production by pentoxifylline and thalidomide | 2 | 3 |
1290 | 0 | 0 | 1710 2000 EUROPEAN HEART JOURNAL 21:367-367 Vescovo G; Ceconi C; Ferrari R; Ambrosio GB; Ravara B; Angelini A; Corti A; Rossini K; Sandri M; Leprotti C; Dalla Libera L Does thalidomide block apoptosis and prevent from the development of skeletal muscle myopathy in chronic heart failure? | 0 | 0 |
# | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
1291 | 1 | 1 | 1923 2001 EUROPEAN JOURNAL OF CANCER 37(16):1966-1966 [Anon] Thalidomide is back | 0 | 0 |
1292 | 0 | 0 | 2177 2002 EUROPEAN JOURNAL OF CANCER 38:S53-S53 Villalona-Calero M; Duan W; Otterson G; Kleiber B; Hindman K; Shah M; Young D; Wu W; Kuhn J Thalidomide modulation of Irinotecan; an NF-kB dependent effect? | 0 | 0 |
1293 | 0 | 0 | 2178 2002 EUROPEAN JOURNAL OF CANCER 38:S82-S82 Ng SSW; Kruger EA; Luzzio FA; Eger K; Guetschow M; Hauschildt S; Hecker T; Teubert U; Weiss M; Figg WD In vitro antiangiogenic activity of thalidomide analogues | 0 | 0 |
1294 | 0 | 0 | 2452 2003 EUROPEAN JOURNAL OF CANCER 39(7):854-854 [Anon] Thalidomide on trial | 0 | 0 |
1295 | 11 | 31 | 1191 1995 EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY 49(1-2):1-6 HARLAND CC; STEVENTON GB; MARSDEN JR THALIDOMIDE INDUCED NEUROPATHY AND GENETIC-DIFFERENCES IN DRUG-METABOLISM | 20 | 23 |
1296 | 68 | 87 | 1924 2001 EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY 57(5):365-376 Eriksson T; Bjorkman S; Hoglund P Clinical pharmacology of thalidomide | 22 | 32 |
1297 | 26 | 33 | 1140 1994 EUROPEAN JOURNAL OF DERMATOLOGY 4(1):9-15 OCHONISKY S; REVUZ J THALIDOMIDE USE IN DERMATOLOGY | 29 | 34 |
1298 | 18 | 24 | 1260 1996 EUROPEAN JOURNAL OF DERMATOLOGY 6(5):373-376 Charue D; Chauvin E; Duguet C; Revuz J; Bagot M Thalidomide decreases the production of GM-CSF and TNF-alpha in the mixed epidermal cell-lymphocyte reaction | 1 | 2 |
1299 | 13 | 14 | 2179 2002 EUROPEAN JOURNAL OF DERMATOLOGY 12(1):63-65 Frances C; El Khoury S; Gompel A; Becherel PA; Chosidow O; Piette JC Transient secondary amenorrhea in women treated by thalidomide | 1 | 2 |
1300 | 2 | 14 | 1261 1996 EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY 8(9):929-931 Postema PTE; denHaan P; vanHagen PM; vanBlankenstein M Treatment of colitis in Behcet's disease with thalidomide | 12 | 19 |
# | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
1301 | 14 | 33 | 2453 2003 EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY 15(9):951-957 Muriel P; Fernandez-Martinez E; Perez-Alvarez V; Lara-Ochoa F; Ponce S; Garcia J; Shibayama M; Tsutsumi V Thalidomide ameliorates carbon tetrachloride induced cirrhosis in the rat | 0 | 1 |
1302 | 1 | 6 | 2454 2003 EUROPEAN JOURNAL OF HAEMATOLOGY 70(3):198-199 Vicari P; Ribas C; Sampaio M; Arantes AM; Yamamoto M; Reis JB; Segreto RA; Bordin JO; Colleoni GWB Can thalidomide be effective to treat plasma cell leptomeningeal infiltration? | 0 | 0 |
1303 | 16 | 28 | 2619 2004 EUROPEAN JOURNAL OF HAEMATOLOGY 72(1):52-57 Strupp C; Germing U; Scherer A; Kundgen A; Modder U; Gattermann N; Haas R Thalidomide for the treatment of idiopathic myelofibrosis | 0 | 0 |
1304 | 16 | 30 | 2620 2004 EUROPEAN JOURNAL OF HAEMATOLOGY 72(6):403-409 Offidani M; Corvatta L; Marconi M; Malerba L; Mele A; Olivieri A; Brunori M; Catarini M; Candela M; Capelli D; Montanari M; Rupoli S; Leoni P Common and rare side-effects of low-dose thalidomide in multiple myeloma: focus on the dose-minimizing peripheral neuropathy | 0 | 0 |
1305 | 11 | 26 | 2621 2004 EUROPEAN JOURNAL OF HAEMATOLOGY 73(2):98-103 Tosi P; Zamagni E; Cellini C; Cangini D; Tacchetti P; Tura S; Baccarani M; Cavo M Thalidomide alone or in combination with dexamethasone in patients with advanced, relapsed or refractory multiple myeloma and renal failure | 0 | 0 |
1306 | 5 | 25 | 2180 2002 EUROPEAN JOURNAL OF HEART FAILURE 4(4):455-460 Vescovo G; Ravara B; Angelini A; Sandri M; Carraro U; Ceconi C; Libera LD Effect of thalidomide on the skeletal muscle in experimental heart failure | 1 | 2 |
1307 | 2 | 13 | 750 1981 EUROPEAN JOURNAL OF PEDIATRICS 136(3):229-230 BURGIO GR THE THALIDOMIDE DISASTER BRIEFLY REVISITED | 3 | 4 |
1308 | 0 | 16 | 783 1982 EUROPEAN JOURNAL OF PEDIATRICS 138(1):77-80 VANREGEMORTER N; HAUMONT D; KIRKPATRICK C; VISEUR P; JEANTY P; DODION J; MILAIRE J; ROOZE M; RODESCH F HOLT ORAM SYNDROME MISTAKEN FOR THALIDOMIDE EMBRYOPATHY - EMBRYOLOGICAL CONSIDERATIONS | 1 | 6 |
1309 | 3 | 38 | 944 1987 EUROPEAN JOURNAL OF PEDIATRICS 146(1):63-67 SCHAFER KH; KRAMER M INFANTILE HYPERTROPHIC PYLORIC-STENOSIS AFTER PRENATAL EXPOSURE TO THALIDOMIDE | 0 | 0 |
1310 | 4 | 22 | 2622 2004 EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES 21(4):465-469 Abraham MH Hydrogen bond and other descriptors for thalidomide and its N-alkyl analogs; prediction of physicochemical and biological properties | 0 | 0 |
# | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
1311 | 3 | 42 | 883 1985 EUROPEAN JOURNAL OF PHARMACOLOGY 119(1-2):39-46 YOUDIM MBH; ASHKENAZI R SEROTONERGIC INVOLVEMENT IN PHARMACOLOGICAL ACTION OF THE ANXIOLYTIC-SEDATIVES THALIDOMIDE AND SUPIDIMIDE | 0 | 1 |
1312 | 10 | 34 | 1711 2000 EUROPEAN JOURNAL OF PHARMACOLOGY 391(1-2):97-103 Ribeiro RA; Vale ML; Ferreira SH; Cunha FQ Analgesic effect of thalidomide on inflammatory pain | 3 | 16 |
1313 | 19 | 36 | 2181 2002 EUROPEAN JOURNAL OF PHARMACOLOGY 453(2-3):325-334 Thiele A; Bang R; Gutschow M; Rossol M; Loos S; Eger K; Tiegs G; Hauschildt S Cytokine modulation and suppression of liver injury by a novel analogue of thalidomide | 1 | 3 |
1314 | 8 | 23 | 2182 2002 EUROPEAN JOURNAL OF SURGERY 168(11):641-645 Mall JW; Schwenk W; Philipp AW; Muller JM; Pollmann C Thalidomide given intraperitoneally reduces the number of postoperative adhesions after large bowel resection in rabbits | 0 | 0 |
1315 | 11 | 14 | 1011 1990 EUROPEAN SURGICAL RESEARCH 22(6):336-339 EMRE S; SUMRANI N; HONG J BENEFICIAL EFFECT OF THALIDOMIDE AND CICLOSPORIN COMBINATION IN HETEROTOPIC CARDIAC TRANSPLANTATION IN RATS | 5 | 5 |
1316 | 29 | 116 | 101 1962 EXPERIENTIA 18(9):389-& FAIGLE JW; SCHMID K; RIESS W; KEBERLE H METABOLIC FATE OF THALIDOMIDE | 73 | 124 |
1317 | 2 | 4 | 216 1963 EXPERIENTIA 19(12):645-& OBBINK HJK; DALDERUP LM EFFECTS OF THALIDOMIDE IN RAT FOETUS | 0 | 7 |
1318 | 0 | 1 | 281 1964 EXPERIENTIA 20(5):283-& OBBINK HJK; DALDERUP LM EFFECTS OF THALIDOMIDE ON SKELETON OF RAT FOETUS | 2 | 3 |
1319 | 8 | 13 | 334 1965 EXPERIENTIA 21(11):672-& SAWIN PB; CRARY D; FOX RR; WUEST HM THALIDOMIDE MALFORMATIONS AND GENETIC BACKGROUND IN RABBIT | 9 | 23 |
1320 | 0 | 7 | 377 1966 EXPERIENTIA 22(10):669-& RINALDI L ACTION OF THALIDOMIDE ON ENDOSTEAL OSSIFICATION IN PIGEON | 1 | 2 |
# | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
1321 | 3 | 10 | 459 1968 EXPERIENTIA 24(10):993-& WUEST HM; FOX RR; CRARY DD RELATIONSHIP BETWEEN TERATOGENY AND STRUCTURE IN THALIDOMIDE FIELD | 7 | 14 |
1322 | 3 | 11 | 502 1970 EXPERIENTIA 26(3):305-& MIURA M; WUEST H POTENTIATING EFFECT OF THALIDOMIDE ON METHYLCHOLANTHRENE ONCOGENESIS IN MICE | 2 | 5 |
1323 | 2 | 15 | 503 1970 EXPERIENTIA 26(7):796-& AMIRKHAN.JD THALIDOMIDE AS A MUTAGENIC AGENT IN MOSQUITO (CULEX-PIPIENS MOLESTUS) | 0 | 1 |
1324 | 2 | 5 | 521 1971 EXPERIENTIA 27(4):421-& KOHLER F; OCKENFEL.H COMPENSATION OF TERATOGENIC EFFECT OF A THALIDOMIDE METABOLITE BY L-GLUTAMIC ACID | 3 | 7 |
1325 | 4 | 15 | 522 1971 EXPERIENTIA 27(6):671-& ECKERT T; DORR NW INTERMOLECULAR INTERACTIONS OF FOLIC ACID WITH N-PHTHALOYL-DL-GLUTAMIC ACID PROBLEM OF TERATOGENIC ACTION OF THALIDOMIDE | 1 | 2 |
1326 | 7 | 13 | 523 1971 EXPERIENTIA 27(10):1149-& KOHLER F; MEISE W; OCKENFEL.H TERATOLOGICAL TESTING OF SOME THALIDOMIDE METABOLITES | 6 | 17 |
1327 | 8 | 17 | 568 1973 EXPERIENTIA 29(4):423-424 MEISE W; OCKENFEL.H; KOHLER F TERATOLOGICAL TESTING OF HYDROLYTIC PRODUCTS OF THALIDOMIDE | 9 | 15 |
1328 | 3 | 5 | 621 1976 EXPERIENTIA 32(5):597-599 STOKES PA; LYKKE AWJ; MCBRIDE WG ULTRASTRUCTURAL CHANGES IN DORSAL ROOT-GANGLIA EVOKED BY THALIDOMIDE IN RABBITS | 0 | 3 |
1329 | 1 | 7 | 646 1977 EXPERIENTIA 33(9):1227-1228 HAGSTROM BE; LONNING S TERATOGENIC ACTION OF THALIDOMIDE ON MARINE FISH LARVAE | 0 | 2 |
1330 | 5 | 17 | 647 1977 EXPERIENTIA 33(10):1384-1386 PETTER C EARLY FETAL THROMBOSIS INDUCED BY THALIDOMIDE IN MOUSE - POSSIBLE EXPLANATION FOR TERATOGENICITY | 7 | 11 |
# | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
1331 | 1 | 8 | 884 1985 EXPERIMENTAL ANIMALS 34(3):295-302 MATSUBARA Y; MIKAMI T TERATOGENIC POTENTIALITY OF SINGLE DOSE OF THALIDOMIDE IN JW-NIBS RABBITS | 0 | 1 |
1332 | 0 | 37 | 2623 2004 EXPERIMENTAL BRAIN RESEARCH 156(3):333-341 Stoeckel MC; Pollok B; Schnitzler A; Witte OW; Seitz RJ Use-dependent cortical plasticity in thalidomide-induced upper extremity dysplasia: evidence from somaesthesia and neuroimaging | 0 | 0 |
1333 | 23 | 41 | 1336 1997 EXPERIMENTAL EYE RESEARCH 64(6):971-978 Kenyon BM; Browne F; DAmato RJ Effects of thalidomide and related metabolites in a mouse corneal model of neovascularization | 96 | 149 |
1334 | 0 | 0 | 945 1987 EXPERIMENTAL HEMATOLOGY 15(5):476-476 HULLIN R; VOGELSANG GB; BRUNDRETTE R; COLVIN OM; SANTOS GW; HESS AD INTRACELLULAR BINDING-PROTEINS FOR THALIDOMIDE | 0 | 0 |
1335 | 0 | 0 | 1043 1991 EXPERIMENTAL HEMATOLOGY 19(6):553-553 VOGELSANG GB; BUJNOVSZKY C; BOUCHER C; LEONG K; JALALIAN M; HESS A; SANTOS GW INVITRO IMMUNOLOGICAL EFFECTS OF THALIDOMIDE | 0 | 0 |
1336 | 20 | 52 | 1192 1995 EXPERIMENTAL HEMATOLOGY 23(9):978-985 FERNANDEZ LP; SCHLEGEL PG; BAKER J; CHEN YF; CHAO NJ DOES THALIDOMIDE AFFECT IL-2 RESPONSE AND PRODUCTION | 21 | 21 |
1337 | 1 | 1 | 1193 1995 EXPERIMENTAL HEMATOLOGY 23(12):1324-1324 FERNANDEZ LP; SCHLEGEL PG; BAKER J; CHEN YF; CHAO NJ DOES THALIDOMIDE AFFECT IL-2 RESPONSE AND PRODUCTION (VOL 23, PG 978, 1995) | 1 | 1 |
1338 | 37 | 60 | 1433 1998 EXPERIMENTAL HEMATOLOGY 26(3):217-221 Or R; Feferman R; Shoshan S Thalidomide reduces vascular density in granulation tissue of subcutaneously implanted polyvinyl alcohol sponges in guinea pigs | 18 | 24 |
1339 | 0 | 0 | 1712 2000 EXPERIMENTAL HEMATOLOGY 28(7):103-104 Raza A; Lisak L; Little L; Andrews C; Meyer P; Ekbal M; Venugopal P Improvement in cytopenias of patients with myelodysplastic syndromes (MDS) in response to thalidomide | 0 | 0 |
1340 | 0 | 0 | 1713 2000 EXPERIMENTAL HEMATOLOGY 28(7):110-110 Janssen WE; Dalton WS Improved blood hematopoietic progenitor mobilization in myeloma patients following treatment with thalidomide | 0 | 0 |
# | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
1341 | 0 | 0 | 2183 2002 EXPERIMENTAL HEMATOLOGY 30(6):60-60 Biscardi M; Gavazzi S; Balestri F; Grossi A Angiogenic growth factors (VEGF, TGF-b1, bFGF) and thalidomide effect in myelofibrosis with myeloid metaplasia | 0 | 0 |
1342 | 0 | 0 | 2184 2002 EXPERIMENTAL HEMATOLOGY 30(6):98-98 Mohty M; Blaise D; Isnardon D; Olive D; Gaugler B Differential regulation of dendritic cell function by the immunomodulatory drug thalidomide: implications for multiple myeloma therapy | 0 | 0 |
1343 | 0 | 0 | 2185 2002 EXPERIMENTAL HEMATOLOGY 30(6):98-98 Schey S; Jones R; Raj K; Streetley M A phase I study of an immunomodulatory thalidomide analogue (CC4047) in relapse/refractory multiple myeloma | 0 | 0 |
1344 | 0 | 0 | 2455 2003 EXPERIMENTAL HEMATOLOGY 31(7):198-198 Moutouh-De Parseval L; Glezer E; Corral L; Galliher A; Wu J; Brady H; Mercurio F; Chan K Immunomodulatory thalidomide analogs modulate hematopoietic stem cell developmental pathways | 0 | 0 |
1345 | 44 | 53 | 1925 2001 EXPERT OPINION ON BIOLOGICAL THERAPY 1(4):675-682 Marriott JB; Muller G; Stirling D; Dalgleish AG Immunotherapeutic and antitumour potential of thalidomide analogues | 11 | 15 |
1346 | 74 | 144 | 2456 2003 EXPERT OPINION ON INVESTIGATIONAL DRUGS 12(7):1211-1225 Fanelli M; Sarmiento R; Gattuso D; Carillio G; Capaccetti B; Vacca A; Roccaro AM; Gasparini G Thalidomide: a new anticancer drug? | 2 | 6 |
1347 | 42 | 78 | 2624 2004 EXPERT OPINION ON THERAPEUTIC PATENTS 14(2):215-229 Luzzio FA; Figg WD Thalidomide analogues: derivatives of an orphan drug with diverse biological activity | 0 | 0 |
1348 | 0 | 1 | 378 1966 EYE EAR NOSE AND THROAT MONTHLY 45(4):74-& [Anon] THALIDOMIDE LEGACY | 0 | 0 |
1349 | 9 | 18 | 2186 2002 FARMACO 57(7):551-554 Blaschke G; Meyring M; Muhlenbrock C; Chankvetadze B Recent results of biotransformation of drugs: investigation of the in vitro biotransformation of thalidomide using a dual cyclodextrin system in capillary electrophoresis | 0 | 2 |
1350 | 0 | 0 | 1262 1996 FASEB JOURNAL 10(6):303-303 Shannon EJ; Sandoval F; Krahenbuhl J Hydrolysis of thalidomide abrogates its ability to enhance IL-2 or to suppress TNF-alpha. | 0 | 0 |
# | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
1351 | 0 | 0 | 1434 1998 FASEB JOURNAL 12(4):A262-A262 Rowland TL; McHugh SM; Ewan PW; Lachmann PJ; Dearman RJ; Kimber I Down-regulation of T-cell and non-T-cell derived tumor necrosis factor alpha by thalidomide and dexamethasone | 0 | 0 |
1352 | 0 | 0 | 1714 2000 FASEB JOURNAL 14(8):A1512-A1512 Cornely KA; Bennett NS Thalidomide makes a comeback: A case study exercise that integrates biochemistry and organic chemistry | 0 | 0 |
1353 | 0 | 0 | 1926 2001 FASEB JOURNAL 15(4):A556-A556 Jajeh A; Boulos B; Youakim J; Ali M; Woynarowsky A In vitro reduction of accelerated apoptosis of neutrophils in blood drawn from an HIV positive subject with Thalidomide. | 0 | 0 |
1354 | 0 | 0 | 2457 2003 FASEB JOURNAL 17(7):C124-C124 Dredge K; Marriott JB; Todryk SM; Klaschka D; Horsfall R; Dalgleish A The role of thalidomide-related IMiDs in the induction of innate and adaptive anti-tumor immunity | 0 | 0 |
1355 | 0 | 0 | 2625 2004 FASEB JOURNAL 18(4):A68-A68 Segarra M; Lozano E; Vilardell C; Esparza J; Izco N; Blade J; Campo E; Cid MC Thalidomide (Thd) decreases Fibronectin (FN)-induced gelatinase (MMP-2 and MMP-9) production by B lymphoid cell lines | 0 | 0 |
1356 | 0 | 0 | 8 1960 FEDERATION PROCEEDINGS 19(1):264-264 KUHN WL; VANMAANEN EF EFFECTS OF THALIDOMIDE ON CENTRAL NERVOUS SYSTEM DRUGS | 2 | 4 |
1357 | 0 | 0 | 217 1963 FEDERATION PROCEEDINGS 22(2):368-& WILLIAMS M; SPARLING F; WEST FR INTRAVENOUS ADMINISTRATION OF ALPHA-PHTHALIMIDOGLUTARIMIDE (THALIDOMIDE) | 0 | 2 |
1358 | 0 | 0 | 218 1963 FEDERATION PROCEEDINGS 22(2):666-& DIPAOLO JA THALIDOMIDE - INFLUENCE ON PRODUCTION OF CONGENITAL ABNORMALITIES IN MICE AND CANCER CHEMOTHERAPY | 3 | 4 |
1359 | 0 | 0 | 282 1964 FEDERATION PROCEEDINGS 23(2P1):243-& FRIEDMAN L; SHUE GM; HOVE EL RESPONSE OF RATS TO THALIDOMIDE AS INFLUENCED BY RIBOFLAVIN DEFICIENCY | 0 | 0 |
1360 | 0 | 0 | 379 1966 FEDERATION PROCEEDINGS 25(2P1):353-& SCHUMACHER H; GILLETTE J EMBRYOTOXIC EFFECTS OF THALIDOMIDE | 2 | 3 |
# | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
1361 | 0 | 0 | 380 1966 FEDERATION PROCEEDINGS 25(2P1):532-& MORI A; NYHAN WL; ASHIDA H METABOLISM OF THALIDOMIDE IN PREGNANT RATS | 4 | 5 |
1362 | 2 | 6 | 381 1966 FEDERATION PROCEEDINGS 25(5P2S):T910-& ALEKSAND.PN; BOGDANOV.VA; CHERNUKH AM TERATOGENIC ACTION OF INTERMEDIATE PRODUCTS OF THALIDOMIDE SYNTHESIS ON CHICK EMBRYO | 0 | 1 |
1363 | 0 | 0 | 460 1968 FEDERATION PROCEEDINGS 27(2):494-& OGILVIE JW; KANTOR FS EFFECT OF THALIDOMIDE ON IMMUNE RESPONSE | 4 | 4 |
1364 | 0 | 0 | 483 1969 FEDERATION PROCEEDINGS 28(2):743-& WILLIAMS JP THALIDOMIDE AND DNA SYNTHESIS | 0 | 1 |
1365 | 0 | 1 | 592 1974 FEDERATION PROCEEDINGS 33(3):577-577 FREDERIC.RC; HARVEY CH; JONES GT; DUSENBER.WE DIFFERENT INTERACTIONS OF THALIDOMIDE (T) AND NEMBUTAL (N) WITH HYPNOTIC EFFECTS OF STIMULATION IN BASAL FOREBRAIN (BF) | 0 | 0 |
1366 | 0 | 0 | 666 1978 FEDERATION PROCEEDINGS 37(3):503-503 GORDON G; BLAKE DA IS THALIDOMIDE A MUTAGENT | 2 | 2 |
1367 | 0 | 0 | 751 1981 FEDERATION PROCEEDINGS 40(3):668-668 GORDON GB; SPIELBERG SP; BLAKE DA; BALASUBRAMANIAN V THALIDOMIDE TERATOGENESIS - EVIDENCE FOR A TOXIC ARENE OXIDE METABOLITE | 0 | 0 |
1368 | 0 | 0 | 885 1985 FEDERATION PROCEEDINGS 44(6):1881-1881 VOGELSANG G; GORDON G; HORWITZ L; SANTOS G; HESS A IMMUNOSUPPRESSIVE ACTIVITY OF THALIDOMIDE | 0 | 2 |
1369 | 4 | 31 | 1194 1995 FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY 12(3-4):165-174 GEIST C; WOHRMANN T; SCHNEIDER J; ZWINGENBERGER K EFFECTS OF THALIDOMIDE ON THE LOCAL SHWARTZMAN REACTION IN MICE AND RABBITS | 6 | 8 |
1370 | 0 | 0 | 2187 2002 FERTILITY AND STERILITY 77(2):S28-S28 Zhong S; Shen K; Lang J The effects of thalidomide on interleukin-6 and vascular endothelial growth factor expression of endometrial stromal cell in vitro. | 0 | 0 |
# | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
1371 | 0 | 0 | 2188 2002 FERTILITY AND STERILITY 78(3):S87-S87 Scarpellini F; Sbracia M; Lecchini S; Scarpellini L Anti-angiogenesis treatment with thalidomide in endometriosis: A pilot study. | 0 | 1 |
1372 | 13 | 24 | 1141 1994 FOLIA BIOLOGICA 40(4):161-171 BILA V; KREN V EVIDENCE FOR TERATOGENICITY OF THALIDOMIDE USING CONGENIC AND RECOMBINANT INBRED RAT STRAINS | 0 | 10 |
1373 | 0 | 62 | 667 1978 FOLIA HISTOCHEMICA ET CYTOCHEMICA 16(3):233-& SZYDLOWSKA H; DLUZNIEWSKI A APPLICATION OF THALIDOMIDE AS A BLOCK OF FUNCTIONAL-GROUPS OF PROTEINS IN HISTOCHEMICAL INVESTIGATIONS | 0 | 0 |
1374 | 4 | 12 | 484 1969 FOLIA PRIMATOLOGICA 10(3):195-& BARROW MV; STEFFEK AJ; KING CTG THALIDOMIDE SYNDROME IN RHESUS MONKEYS (MACACA MULATTA) | 4 | 9 |
1375 | 0 | 3 | 921 1986 FOOD AND CHEMICAL TOXICOLOGY 24(6-7):635-636 NEWALL DR; TESH JM EMBRYO CULTURE AS AN EARLY SCREEN FOR TERATOGENIC POTENTIAL .2. THALIDOMIDE | 0 | 2 |
1376 | 0 | 18 | 611 1975 FOOD AND COSMETICS TOXICOLOGY 13(1):55-61 KENNEDY GL; ARNOLD DW; KEPLINGER ML MUTAGENICITY STUDIES WITH CAPTAN, CAPTOFOL, FOLPET AND THALIDOMIDE | 0 | 18 |
1377 | 8 | 28 | 922 1986 FOOD AND DRUG LAW JOURNAL 41(4):458-466 SHERMAN M; STRAUSS S THALIDOMIDE - A 25-YEAR PERSPECTIVE | 4 | 14 |
1378 | 0 | 0 | 726 1980 FORTSCHRITTE DER MEDIZIN 98(11):405-409 RUFFING L MALFORMATIONS OF THE SPINE IN PATIENTS WITH THALIDOMIDE EMBRYOPATHY | 0 | 0 |
1379 | 6 | 29 | 569 1973 FORTSCHRITTE DER NEUROLOGIE PSYCHIATRIE 41(7):378-417 GIBBELS E; SCHEID W; WIECK HH; KINZEL W THALIDOMIDE-NEUROPATHY IN LATE STAGE | 6 | 5 |
1380 | 2 | 53 | 524 1971 FORTSCHRITTE DER NEUROLOGIE UND PSYCHIATRIE UND IHRER GRENZGEBIETE 39(1):15-& KRUCKE W; HARTROTT HH; SCHRODER JM; THOMAS E; GIBBELS E; SCHEID W LIGHT AND ELECTRON MICROSCOPIC STUDIES ON LATE STAGE OF THALIDOMIDE POLYNEUROPATHY | 13 | 18 |
# | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
1381 | 0 | 0 | 1337 1997 FORTUNE 136(6):36-& McLean B Thalidomide .2. | 0 | 0 |
1382 | 0 | 0 | 1927 2001 FREE RADICAL BIOLOGY AND MEDICINE 31:S54-S54 Hansen JM; Gong SG; Harris C Thalidomide (TD) depletes glutathione and alters gene expression in the developing limb. | 0 | 0 |
1383 | 7 | 11 | 968 1988 FUNDAMENTAL & CLINICAL PHARMACOLOGY 2(6):493-497 DESCOTES J; TEDONE R; EVREUX JC ENHANCEMENT OF ANTIBODY-RESPONSE AND DELAYED-TYPE HYPERSENSITIVITY BY THALIDOMIDE IN MICE | 3 | 3 |
1384 | 2 | 10 | 283 1964 GANN 55(1):57-& SUGIURA K; WUEST HM EFFECT OF THALIDOMIDE ON TRANSPLANTABLE MOUSE RAT + HAMSTER TUMORS | 1 | 6 |
1385 | 3 | 6 | 820 1983 GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE 7(8-9):751-751 COUZIGOU P; DOUTRE MS; HOUDEE G; RICHARDMOLARD B; FLUERY B; AMOURETTI M; BEYLOT C; BERAUD C THALIDOMIDE IN THE TREATMENT OF BEHCETS SYNDROME | 0 | 9 |
1386 | 0 | 2 | 851 1984 GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE 8(2):196-196 ROGE J; TESTAS P THALIDOMIDE IN BEHCETS SYNDROME | 6 | 7 |
1387 | 1 | 6 | 994 1989 GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE 13(1):104-104 PATEY O; CHARASZ N; ROUCAYROL AM; MALKIN JE; LAFAIX C THALIDOMIDE AND INTESTINAL INVOLVEMENT IN BEHCETS SYNDROME | 2 | 3 |
1388 | 5 | 5 | 1195 1995 GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE 19(1):128-129 SIRE S; FRAISSE P; REY D; JACQUEMIN C; KEMPF G; PARTISANI M; LANG JM EFFECTIVENESS OF THALIDOMIDE IN THE TREATMENT OF ESOPHAGEAL ULCERS IN AIDS | 2 | 2 |
1389 | 0 | 1 | 1097 1993 GASTROENTEROLOGY 104(4):A683-A683 COHEN LB; PEAREN S; IAZZETTA J THALIDOMIDE FOR INFLAMMATORY BOWEL-DISEASE - A PRELIMINARY-REPORT | 0 | 0 |
1390 | 8 | 15 | 1098 1993 GASTROENTEROLOGY 105(3):956-956 RHOTON AJ ROLE FOR THALIDOMIDE IN PRIMARY BILIARY-CIRRHOSIS TREATMENT | 0 | 0 |
# | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
1391 | 11 | 39 | 1338 1997 GASTROENTEROLOGY 112(6):1823-1829 Sharpstone D; Rowbottom A; Francis N; Tovey G; Ellis D; Barrett M; Gazzard B Thalidomide: A novel therapy for microsporidiosis | 12 | 42 |
1392 | 0 | 0 | 1435 1998 GASTROENTEROLOGY 114(4):A1008-A1008 Kenet G; Avni Y; Aeed H; Shirin H; Matas Z; Zaidel L; Galor S; Hershkovitz R; Bruck R Iodoacetamide-induced colitis in rats is inhibited by thalidomide. | 0 | 0 |
1393 | 0 | 0 | 1539 1999 GASTROENTEROLOGY 116(4):A745-A745 Kane SV; Ehrenpreis ED; Cohen LB; Hanauer SB; Cohen RD Therapeutic efficacy of thalidomide for patients with refractory Crohn's disease (CD) | 2 | 5 |
1394 | 0 | 0 | 1540 1999 GASTROENTEROLOGY 116(4):A767-A767 Macumber C; Wettstein AP; Vickers CR; Hing M; Edwards PD; Byrnes DJ; Meagher AP Thalidomide-effective therapy in chronic resistant inflammatory bowel disease. Department of gastroenterology. St. Vincent's Hospital, Sydney, Australia. | 2 | 3 |
1395 | 0 | 0 | 1541 1999 GASTROENTEROLOGY 116(4):A837-A837 Vasiliauskas EA; Kam LY; Abreu-Martin MT; Papadakis KA; Zeldis JB; Targan SR An open-label, stepwise dose-escalating pilot study to evaluate the safety, tolerance, & efficacy of low-dose thalidomide in the treatment of chronically-active, steroid-department Crohn's disease (CD) | 3 | 0 |
1396 | 0 | 0 | 1542 1999 GASTROENTEROLOGY 116(4):A843-A843 Wedel S; Bauditz J; Suk A; Lochs H Efficacy of thalidomide in Crohn's disease. | 2 | 3 |
1397 | 21 | 33 | 1543 1999 GASTROENTEROLOGY 117(6):1271-1277 Ehrenpreis ED; Kane SV; Cohen LB; Cohen RD; Hanauer SB Thalidomide therapy for patients with refractory Crohn's disease: An open-label trial | 44 | 131 |
1398 | 19 | 40 | 1544 1999 GASTROENTEROLOGY 117(6):1278-1287 Vasiliauskas EA; Kam LY; Abreu-Martin MT; Hassard PV; Papadakis KA; Yang HY; Zeldis JB; Targan SR An open-label pilot study of low-dose thalidomide in chronically active, steroid-dependent Crohn's disease | 43 | 129 |
1399 | 23 | 32 | 1545 1999 GASTROENTEROLOGY 117(6):1485-1488 Sands BE; Podolsky DK New life in a sleeper: Thalidomide and Crohn's disease | 8 | 25 |
1400 | 0 | 0 | 1715 2000 GASTROENTEROLOGY 118(4):A580-A580 Bauditz L; Wedel S; Suk A; Lochs H Cytokine profiles under treatment with Thalidomide steroid-resistant Crohn's disease. | 0 | 0 |
# | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
1401 | 0 | 0 | 1716 2000 GASTROENTEROLOGY 118(4):A582-A582 Kam LY; Vasiliauskas EA; Abreu MT; Hassard PV; Zeldis J; Targan SR Open labeled pilot study of thalidomide(thal) as a novel therapy for medically resistant ulcerative colitis (UC). | 1 | 6 |
1402 | 0 | 0 | 1717 2000 GASTROENTEROLOGY 118(4):A586-A586 Prehn JL; Muller GW; Man HW; Stirling DJ; Targan SR Thalidomide analogs, but not thalidomide itself, are potent inhibitors of lamina propria mononuclear cell (LPMC) TNF-A and IFN-Gamma production in response to T cell stimuli. | 0 | 0 |
1403 | 4 | 8 | 1718 2000 GASTROENTEROLOGY 119(2):596-596 Fishman SJ; Feins NR; D'Amato RJ; Folkman J Thalidomide therapy for Crohn's disease | 5 | 12 |
1404 | 0 | 0 | 1928 2001 GASTROENTEROLOGY 120(5):A278-A278 Stein DJ; Rafiee P; Taras A; Lamirand TH; Fisher PJ; Ogawa H; Telford GL; Otterson MF; Johnson CP; Binion DG Thalidomide inhibits inflammatory and angiogenic activation of human intestinal microvascular endothelial cells (HIMEC). | 0 | 0 |
1405 | 0 | 0 | 1929 2001 GASTROENTEROLOGY 120(5):A611-A612 Khan ZH; Cole AT; MacDonald I; Pye D; Austin A; Freeman JG The role of thalidomide in reversing cachexia in patients with inoperable oesophageal cancers | 0 | 0 |
1406 | 6 | 6 | 1930 2001 GASTROENTEROLOGY 120(6):1567-1568 Fox MR; Harris A Intractable insomnia after cessation of treatment with thalidomide | 3 | 3 |
1407 | 1 | 1 | 1931 2001 GASTROENTEROLOGY 121(3):747-747 Fox MR; Harris A Intractable insomnia after cessation of treatment with Thalidomide. (vol 120, pg 1567, 2001) | 0 | 0 |
1408 | 0 | 0 | 2189 2002 GASTROENTEROLOGY 122(4):A194-A194 Bauditz J; Wedel S; Lochs H Thalidomide for treatment of intestinal bleeding: Correlation to VEGF | 1 | 1 |
1409 | 0 | 0 | 2190 2002 GASTROENTEROLOGY 122(4):A395-A395 Kim JW; Kim SG; Kim HD; Kim CG; Kim BG; Kim JS; Jung HC; Song IS Effect of DA-6034 and thalidomide on trinitrobenzene sulfonic acid-induced murine ileitis | 0 | 0 |
1410 | 0 | 0 | 2191 2002 GASTROENTEROLOGY 122(4):A498-A498 Sabate JM; Villarejo J; Lemann M; Bonnet J; Allez M; Modigliani R An open-label study of thalidomide for maintenance therapy in responders to infliximab in chronically active and fistulizing refractory Crohn's disease | 0 | 0 |
# | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
1411 | 13 | 38 | 2192 2002 GASTROENTEROLOGY 123(1):291-300 Enomoto N; Takei Y; Hirose M; Ikejima K; Miwa H; Kitamura T; Sato N Thalidomide prevents alcoholic liver injury in rats through suppression of Kupffer cell sensitization and TNF-alpha production | 3 | 12 |
1412 | 0 | 0 | 2458 2003 GASTROENTEROLOGY 124(4):A10-A10 Jin SH; Kim WH; Kim TI; Yang KM; Shin SK; Lee SK; Park SJ; Choi CH; Lee WJ Thalidomide destabilizes cyclooxygenase-2 mRNA by inhibiting p38 mitogen-activated protein kinase and cytoplasmic shuttling of HuR | 0 | 0 |
1413 | 0 | 0 | 2459 2003 GASTROENTEROLOGY 124(4):A336-A336 Kim YS; Kim JS; Jung HC; Song IS The effects of thalidomide on NF-R activity and TNF-production stimulated with lipopolysaccharide in a human colonic epithelial cell line ka | 0 | 0 |
1414 | 0 | 0 | 2460 2003 GASTROENTEROLOGY 124(4):A525-A525 Gupta P; Andrew H; Kirschner BS Thalidomide therapy for pediatric patients with refractory Crohn's disease not responding to infliximab | 0 | 0 |
1415 | 9 | 14 | 1263 1996 GASTROINTESTINAL ENDOSCOPY 44(6):729-731 Bellomo A; SchorrLesnick B Thalidomide treatment for idiopathic esophageal ulcers in patients with HIV | 0 | 1 |
1416 | 0 | 0 | 1012 1990 GAZETTE MEDICALE 97(3):26-27 BELAICH S USE OF THALIDOMIDE IN DERMATOLOGY | 0 | 0 |
1417 | 8 | 32 | 622 1976 GEBURTSHILFE UND FRAUENHEILKUNDE 36(12):1066-1070 HOFFMANN W; GROSPIETSCH G; KUHN W GENITAL MALFORMATIONS IN THALIDOMIDE-DAMAGED GIRLS | 0 | 7 |
1418 | 2 | 33 | 852 1984 GEBURTSHILFE UND FRAUENHEILKUNDE 44(4):243-248 MUHLENSTEDT D; SCHWARZ M GYNECOLOGICAL AND ENDOCRINOLOGICAL INVESTIGATIONS IN WOMEN DAMAGED BY THALIDOMIDE | 0 | 0 |
1419 | 0 | 9 | 1013 1990 GEBURTSHILFE UND FRAUENHEILKUNDE 50(11):899-900 SCHAEFER C; SPIELMANN H COCAINE AND PREGNANCY - SHADES OF THE THALIDOMIDE TRAGEDY | 0 | 0 |
1420 | 0 | 0 | 1436 1998 GEBURTSHILFE UND FRAUENHEILKUNDE 58(3):M55-M58 Kosenow W Forty years ago: Thalidomide and its consequences | 0 | 0 |
# | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
1421 | 7 | 29 | 1196 1995 GENERAL PHARMACOLOGY 26(6):1243-1247 KROGER H; KLEWER M; GRATZ R; DIETRICH A; OCKENFELS H; MIESEL R EXACERBATION OF ACETAMINOPHEN HEPATOTOXICITY BY THALIDOMIDE AND PROTECTION BY NICOTINIC-ACID AMIDE | 1 | 2 |
1422 | 3 | 4 | 1057 1992 GENITOURINARY MEDICINE 68(6):424-425 STRAZZI S; LEBBE C; GEOFFRAY C; ABLON G; MOREL P; VEROLA O; MOLINA JM APHTHOUS ULCERS IN HIV-INFECTED PATIENTS - TREATMENT WITH THALIDOMIDE | 8 | 10 |
1423 | 0 | 0 | 1719 2000 GESUNDHEITSWESEN 62(8-9):A87-A87 Edler B; Teige B; Nippert I Study on health-related quality of life among women with developmental retardation - Case of thalidomide victims | 0 | 0 |
1424 | 8 | 31 | 1058 1992 GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY 230(2):140-149 STROMLAND K; MILLER MT REFRACTIVE EVALUATION IN THALIDOMIDE EMBRYOPATHY | 3 | 5 |
1425 | 10 | 14 | 1197 1995 GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY 233(2):90-93 GUEXCROSIER Y; PITTET N; HERBORT CP THE EFFECT OF THALIDOMIDE AND SUPIDIMIDE ON ENDOTOXIN-INDUCED UVEITIS IN RATS | 5 | 6 |
1426 | 13 | 27 | 1437 1998 GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY 236(6):461-466 Kruse FE; Joussen AM; Rohrschneider K; Becker MD; Volcker HE Thalidomide inhibits corneal angiogenesis induced by vascular endothelial growth factor | 39 | 57 |
1427 | 9 | 33 | 1546 1999 GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY 237(12):952-961 Joussen AM; Germann T; Kirchhof B Effect of thalidomide and structurally related compounds on corneal angiogenesis is comparable to their teratological potency | 4 | 8 |
1428 | 5 | 12 | 1547 1999 GUT 45(3):463-464 Ollivier S; Bonnet J; Lemann M; Coffin JC; Modigliani R; Jian R; Bertheau P; Flejou JF Idiopathic giant oesophageal ulcer in an immunocompetent patient. The efficacy of thalidomide treatment | 1 | 2 |
1429 | 2 | 2 | 1720 2000 GUT 47(1):156-156 Ryan J Thalidomide treatment of oesophageal ulceration | 0 | 0 |
1430 | 0 | 0 | 1932 2001 GUT 48:A48-A48 Khan ZH; Cole AT; Macdonald I; Pye D; Simpson L; Austin A; Freeman JG The role of thalidomide in reversing cachexia in patients with inoperable oesophageal cancer | 0 | 0 |
# | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
1431 | 0 | 0 | 1933 2001 GUT 48:A67-A68 Austin AS; Mahida YR; Ryder SD; Freeman JG Thalidomide but not pentoxifylline lowers portal pressure in human alcoholic cirrhosis | 0 | 0 |
1432 | 0 | 0 | 1934 2001 GUT 48:A89-A90 Trebble T; Johns T; Duncan HD; Goggin PM An open trial of thalidomide in refractory Crohn's colitis | 0 | 0 |
1433 | 0 | 0 | 2193 2002 GUT 50:A4-A4 Khan ZH; Simpson E; Cole AT; Macdonald I; Pye D; Austin A; Freeman JG Oesophageal cancer and cachexia: The effects of thalidomide on weight loss and lean body mass in a sequential (metabolic) study | 1 | 1 |
1434 | 13 | 36 | 2194 2002 GUT 50(2):196-200 Bauditz J; Wedel S; Lochs H Thalidomide reduces tumour necrosis factor alpha and interleukin 12 production in patients with chronic active Crohn's disease | 11 | 25 |
1435 | 6 | 21 | 2626 2004 GUT 53(4):609-612 Bauditz J; Schachschal G; Wedel S; Lochs H Thalidomide for treatment of severe intestinal bleeding | 0 | 0 |
1436 | 4 | 9 | 1721 2000 HAEMATOLOGICA 85(10):1111-1112 Pini M; Baraldi A; Pietrasanta D; Allione B; Depaoli L; Salvi F; Levis A Low-dose thalidomide in the treatment of refractory myeloma | 11 | 19 |
1437 | 0 | 2 | 1935 2001 HAEMATOLOGICA 86(4):348-348 [Anon] Thalidomide in the treatment of multiple myeloma | 0 | 0 |
1438 | 7 | 27 | 1936 2001 HAEMATOLOGICA 86(4):399-403 Palumbo A; Giaccone L; Bertola A; Pregno P; Bringhen S; Rus C; Triolo S; Gallo E; Pileri A; Boccadoro M Low-dose thalidomide plus dexamethasone is an effective salvage therapy for advanced myeloma | 24 | 37 |
1439 | 5 | 21 | 1937 2001 HAEMATOLOGICA 86(4):404-408 Hus M; Dmoszynska A; Soroka-Wojtaszko M; Jawniak D; Legiec W; Ciepnuch H; Hellmann A; Wolska-Smolen T; Skotnicki A; Manko J; Polish Multiple Myeloma Study Grp Thalidomide treatment of resistant or relapsed multiple myeloma patients | 23 | 35 |
1440 | 17 | 33 | 1938 2001 HAEMATOLOGICA 86(4):409-413 Tosi P; Ronconi S; Zamagni E; Cellini C; Grafone T; Cangini D; Pileri SA; Baccarani M; Tura S; Cavo M Salvage therapy with thalidomide in multiple myeloma patients relapsing after autologous peripheral blood stem cell transplantation | 13 | 21 |
# | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
1441 | 0 | 0 | 1939 2001 HAEMATOLOGICA 86(4):448-448 Zappasodi P; Lorenzi A; Corso A Thalidomide in refractory myeloma patients: early changes in bone marrow cellularity | 1 | 1 |
1442 | 2 | 9 | 1940 2001 HAEMATOLOGICA 86(7):772-773 Pozzato G; Zorat F; Nascimben F; Comar C; Kikic F; Festini G Thalidomide therapy in compensated and decompensated myelofibrosis with myeloid metaplasia | 7 | 11 |
1443 | 8 | 10 | 1941 2001 HAEMATOLOGICA 86(10):1108-1109 Camba L; Peccatori J; Pescarollo A; Tresoldi M; Corradini P; Bregni M Thalidomide and thrombosis in patients with multiple myeloma | 10 | 11 |
1444 | 18 | 23 | 2195 2002 HAEMATOLOGICA 87(3):233-234 Tosi P; Cavo M Thalidomide in multiple myeloma: state of art | 3 | 4 |
1445 | 4 | 7 | 2196 2002 HAEMATOLOGICA 87(3):327-328 Corso A; Lorenzi A; Orlandi E; Astori C; Mangiacavalli S; Lazzarino M Advantages of using thalidomide for the management of patients with refractory myeloma | 3 | 4 |
1446 | 13 | 20 | 2197 2002 HAEMATOLOGICA 87(4):344-345 Ribatti D; Vacca A Is thalidomide a true anti-angiogenic molecule in multiple myeloma? | 1 | 1 |
1447 | 14 | 22 | 2198 2002 HAEMATOLOGICA 87(4):345-346 [Anon] Inside Haematologica: caution in the use of thalidomide for treatment of hematologic disorders | 0 | 0 |
1448 | 15 | 35 | 2199 2002 HAEMATOLOGICA 87(4):408-414 Tosi P; Zamagni E; Cellini C; Ronconi S; Patriarca F; Ballerini F; Musto P; Di Raimondo F; Ledda A; Lauria F; Masini L; Gobbi M; Vacca A; Ria R; Cangini D; Tura S; Baccarani M; Cavo M Salvage therapy with thalidomide in patients with advanced relapsed/refractory multiple myeloma | 19 | 28 |
1449 | 3 | 10 | 2200 2002 HAEMATOLOGICA 87(8):884-886 Musto P; Falcone A; Sanpaolo G; Bisceglia M; Matera R; Carella AM Thalidomide abolishes transfusion-dependence in selected patients with myelodysplastic syndromes | 1 | 1 |
1450 | 3 | 10 | 2461 2003 HAEMATOLOGICA 88(5):597-599 Patriarca F; Sperotto A; Prosdocimo S; Geromin A; Zaja F; Fanin R Thalidomide before autologous stem cell transplantation in VAD-refractory multiple myeloma patients | 0 | 0 |
# | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
1451 | 4 | 10 | 2462 2003 HAEMATOLOGICA 88(8):958-960 Corso A; Lorenzi A; Zapposodi P; Invernizzi R; Vanelli L; Lazzarino M Early changes in bone marrow morphology induced by thalidomide in patients with refractory myeloma | 0 | 0 |
1452 | 4 | 10 | 2463 2003 HAEMATOLOGICA 88(12):1432-1433 Offidani M; Marconi M; Corvotta L; Olivieri A; Catarini M; Leoni P Thalidomide plus oral melphalan for advanced multiple myeloma: a phase II study | 0 | 1 |
1453 | 7 | 25 | 2627 2004 HAEMATOLOGICA 89(5):552-556 Brenne AT; Romstad LH; Gimsing P; Juliusson G; Turesson I; Romundstad P; Borset M; Sundan A; Waage A Low serum level of soluble tumor necrosis factor receptor p55 predicts response to thalidomide in advanced multiple myeloma | 0 | 0 |
1454 | 19 | 37 | 2628 2004 HAEMATOLOGICA 89(7):826-831 Cavo M; Zamagni E; Tosi P; Cellini C; Cangini D; Tacchetti P; Testoni N; Tonelli M; De Vivo A; Palareti G; Tura S; Baccarani M First-line therapy with thalidomide and dexamethasone in preparation for autologous stem cell transplantation for multiple myeloma | 0 | 0 |
1455 | 9 | 32 | 2629 2004 HAEMATOLOGICA 89(7):832-836 Rosinol L; Cibeira T; Blade J; Esteve J; Aymerich M; Rozman M; Segarra M; Cid MC; Filella X; Montserrat E Extramedullary multiple myeloma escapes the effect of thalidomide | 0 | 0 |
1456 | 0 | 1 | 696 1979 HASTINGS CENTER REPORT 9(3):43-44 LEVINE C SUFFER THE CHILDREN - STORY OF THALIDOMIDE - SUNDAY-TIMES-OF-LONDON - INSIGHT-TEAM | 0 | 0 |
1457 | 4 | 19 | 612 1975 HAUTARZT 26(1):1-5 SHESKIN J THERAPEUTIC EFFECTS OF THALIDOMIDE IN LEPROSY REACTION | 22 | 25 |
1458 | 0 | 0 | 613 1975 HAUTARZT 26(4):215-215 SHESKIN J THERAPY OF PRURIGO NODULARIS HYDE WITH THALIDOMIDE | 28 | 30 |
1459 | 3 | 9 | 697 1979 HAUTARZT 30(7):376-379 SHESKIN J; YAAR I MOTOR CONDUCTIVITY OF CUBITAL NERVES IN PATIENTS WITH LEPRA REACTION - EXPERIENCE OF 13 YEARS DURING THALIDOMIDE-TREATMENT | 15 | 17 |
1460 | 30 | 66 | 821 1983 HAUTARZT 34(2):66-72 HUNZIKER T; KREBS A THALIDOMIDE IN DERMATOLOGY | 7 | 7 |
# | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
1461 | 5 | 14 | 822 1983 HAUTARZT 34(4):168-170 SHESKIN J; MUCKTER H; FRANKUS E SUPIDIMIDE, A NON-TERATOGENIC ANALOG OF THALIDOMIDE IN THE TREATMENT OF LEPRA REACTIONS | 2 | 2 |
1462 | 7 | 12 | 823 1983 HAUTARZT 34(4):175-178 VOLCPLATZER B; WOLFF K TREATMENT OF SUBACUTE CUTANEOUS LUPUS-ERYTHEMATOSUS WITH THALIDOMIDE | 3 | 6 |
1463 | 7 | 12 | 824 1983 HAUTARZT 34(9):435-436 KNOP J; MACHER E THALIDOMIDE IN THE TREATMENT OF CHRONIC DISCOID LUPUS-ERYTHEMATOSUS | 4 | 4 |
1464 | 6 | 40 | 1198 1995 HAUTARZT 46(8):553-560 DALLAFIOR S; PUGIN P; CERNY T; BETTICHER D; SAURAT JH; HAUSER C A CASE OF CUTANEOUS LANGERHANS CELL GRANULOMATOSIS SUCCESSFULLY TREATED WITH 2-CHLORODEOXYADENOSINE AND THALIDOMIDE | 4 | 9 |
1465 | 5 | 20 | 1942 2001 HAUTARZT 52:962-965 Hoch O; Muller S; Buttner G; Mensing H Thalidomide in the treatment of cutaneous and systemic sarcoidosis | 3 | 5 |
1466 | 5 | 15 | 1943 2001 HAUTARZT 52:966-969 Petering H; Kiehl P; Vogelbruch M; Sticht-Groh V; Kapp A; Werfel T Chemotherapy-induced erythema nodosum leprosum: successful treatment with thalidomide | 0 | 0 |
1467 | 54 | 68 | 1944 2001 HAUTARZT 52(8):726-733 Kuhn A; Hefter H; Ruzicka T; Lehmann P Rediscovery of thalidomide. Successful treatment of discoid lupus erythematosus | 0 | 0 |
1468 | 1 | 8 | 2201 2002 HAUTARZT 53(2):150-150 Ochsendorf F; Kaufman R Thalidomide in the treatment of cutaneous and systemic sarcoidosis | 0 | 0 |
1469 | 2 | 2 | 2202 2002 HAUTARZT 53(2):150-151 Mensing H Thalidomide in the treatment of cutaneous and systemic sarcoidosis - Statement | 0 | 0 |
1470 | 13 | 15 | 2203 2002 HAUTARZT 53(11):744-748 Bohmeyer J; Achenbach A; Westenberger M; Stadler R Thalidomide therapy of cutaneous lupus erythematosus | 1 | 1 |
# | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
1471 | 0 | 1 | 551 1972 HEALTH EDUCATION JOURNAL 31(1):130-130 SIMPSON EE STUDIES IN CHILD DEVELOPMENT - CHALLENGE OF THALIDOMIDE - PRINGLE,MLK AND FIDDES,DO | 0 | 0 |
1472 | 8 | 34 | 1264 1996 HEPATOLOGY 23(6):1616-1621 LopezTalavera JC; Cadelina G; Olchowski J; Merrill W; Groszmann RJ Thalidomide inhibits tumor necrosis factor alpha decreases nitric oxide synthesis, and ameliorates the hyperdynamic circulatory syndrome in portal-hypertensive rats | 7 | 52 |
1473 | 0 | 0 | 1438 1998 HEPATOLOGY 28(4):460A-460A Martinez L; Lopez-Talavera JC; Martinez M; Cadelina G; Pachon JC; Esteban R; Guardia J; Groszmann RJ Amelioration of the hyperdynamic syndrome of cirrhotic rats by thalidomide. | 0 | 0 |
1474 | 0 | 0 | 1722 2000 HEPATOLOGY 32(4):410A-410A Enomoto N; Ikejima K; Hirose M; Ishikawa M; Konno A; Matsuyama S; Shimizu H; Kitamura T; Takei Y; Sato N Thalidomide prevents alcoholic liver injury in rats through suppression of TNF-A production by Kupffer cells. | 0 | 0 |
1475 | 0 | 0 | 1945 2001 HEPATOLOGY 34(4):279A-279A Muriel P; Fernandez-Martinez E; Perez-Alvarez VM; Morales-Rios MS A thalidomide analog with hepatoprotective and antifibrotic properties in biliary obstruction-induced cirrhosis in the rat. | 0 | 0 |
1476 | 0 | 0 | 1946 2001 HEPATOLOGY 34(4):516A-516A Muriel P; Ponce S; Garcia JC Thalidomide partially prevents CCl4-induced liver cirrhosis. | 0 | 0 |
1477 | 0 | 0 | 1947 2001 HEPATOLOGY 34(4):517A-517A Muriel P; Garcia JC; Ponce S; Perez-Alvarez VM; Fernandez-Martinez E; Morales-Rios MS Synthesis and pharmacological evaluation of a thalidomide analog, the 3-phthalimido-3-(3,4-dimethoxyphenyl)propanoic acid in liver cirrhosis induced by bile duct ligation in the rat. | 0 | 0 |
1478 | 21 | 57 | 219 1963 HIROSHIMA JOURNAL OF MEDICAL SCIENCES 12(1):11-& TABUCHI A; SAWASAKI M; UMISA H; SHIRASUN.K; HORIKAWA M; YAMADA A; SHINTANI T PHOCOMELIA-LIKE DEFORMITY AND THALIDOMIDE PREPARATIONS | 3 | 3 |
1479 | 8 | 24 | 2630 2004 HISTOCHEMISTRY AND CELL BIOLOGY 122(1):27-33 Fujita K; Asami Y; Tanaka K; Akita M; Merker HJ Anti-angiogenic effects of thalidomide: expression of apoptosis-inducible active-caspase-3 in a three-dimensional collagen gel culture of aorta | 0 | 0 |
1480 | 0 | 0 | 698 1979 HNO 27(9):302-307 WEIDENBECHER M; MAAK G BEHAVIOR OF THE FACIAL-NERVE IN VITAMIN-A AND THALIDOMIDE INDUCED ATRESIA AURIS CONGENITA - MICROSURGICAL AND HISTOLOGICAL ANIMAL STUDY | 1 | 1 |
# | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
1481 | 22 | 40 | 1723 2000 HUMAN & EXPERIMENTAL TOXICOLOGY 19(11):615-622 Teo S; Evans M; Ehrhart J; Brockman M; Allen D; Morgan M; Stirling D; Thomas S Lack of peripheral neuropathy in Beagle dogs after 53 weeks oral administration of thalidomide capsules | 0 | 0 |
1482 | 4 | 22 | 335 1965 HUMANGENETIK 1(6):516-536 NOWACK E CORRELATION BETWEEN THE PERIOD OF THALIDOMIDE-ADMINISTRATION AND EMBRYOPATHY | 19 | 40 |
1483 | 0 | 0 | 1265 1996 IMMUNOLOGY 89:ORI27-ORI27 Marriott JB; Cookson S; Westby M; Guckian M; Dalgleish AG The effect of a thalidomide analogue on TNF-alpha/cytokine production in vitro | 0 | 0 |
1484 | 0 | 0 | 1266 1996 IMMUNOLOGY 89:E51-E51 Guckian M; Marriott JB; Cookson S; Westby M; Dalgleish G Thalidomide analog 3052 reduces NK activity and PHA-induced proliferation in vitro. | 0 | 0 |
1485 | 16 | 32 | 1548 1999 IMMUNOLOGY LETTERS 68(2-3):325-332 Rowland TL; McHugh SM; Deighton J; Ewan PW; Dearman RJ; Kimber I Selective down-regulation of T cell-and non-T cell-derived tumour necrosis factor alpha by thalidomide: comparisons with dexamethasone | 10 | 13 |
1486 | 43 | 52 | 1549 1999 IMMUNOLOGY TODAY 20(12):538-540 Marriott JB; Muller G; Dalgleish AG Thalidomide as an emerging immunotherapeutic agent | 36 | 45 |
1487 | 10 | 25 | 1199 1995 IMMUNOPHARMACOLOGY 31(1):109-116 SHANNON EJ; SANDOVAL F THALIDOMIDE INCREASES THE SYNTHESIS OF IL-2 IN CULTURES OF HUMAN MONONUCLEAR-CELLS STIMULATED WITH CONCANAVALIN-A, STAPHYLOCOCCAL-ENTEROTOXIN-A, AND PURIFIED PROTEIN DERIVATIVE | 34 | 37 |
1488 | 9 | 28 | 1267 1996 IMMUNOPHARMACOLOGY 31(2-3):213-221 Geitz H; Handt S; Zwingenberger K Thalidomide selectively modulates the density of cell surface molecules involved in the adhesion cascade | 70 | 89 |
1489 | 12 | 22 | 1339 1997 IMMUNOPHARMACOLOGY 35(3):203-212 Shannon EJ; Morales MJ; Sandoval F Immunomodulatory assays to study structure-activity relationships of thalidomide | 10 | 13 |
1490 | 12 | 21 | 1340 1997 IMMUNOPHARMACOLOGY 36(1):9-15 Shannon EJ; Sandoval F; Krahenbuhl JL Hydrolysis of thalidomide abrogates its ability to enhance mononuclear cell synthesis of IL-2 as well as its ability to suppress the synthesis of TNF-alpha | 17 | 18 |
# | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
1491 | 21 | 33 | 1439 1998 IMMUNOPHARMACOLOGY 40(1):11-20 Rowland TL; McHugh SM; Deighton J; Dearman RJ; Ewan PW; Kimber I Differential regulation by thalidomide and dexamethasone of cytokine expression in human peripheral blood mononuclear cells | 36 | 48 |
1492 | 5 | 17 | 1550 1999 IMMUNOPHARMACOLOGY 43(1):59-64 Dunzendorfer S; Herold M; Wiedermann CJ Inducer-specific bidirectional regulation of endothelial interleukin-8 production by thalidomide | 8 | 8 |
1493 | 13 | 20 | 1724 2000 IMMUNOPHARMACOLOGY 46(2):175-179 Shannon E; Aseffa A; Pankey G; Sandoval F; Lutz B Thalidomide's ability to augment the synthesis of IL-2 in vitro in HIV-infected patients is associated with the percentage of CD4+cells in their blood | 8 | 8 |
1494 | 9 | 34 | 1142 1994 IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY 16(4):717-729 SHANNON EJ; HOWE RC; MCLEAN K; HASTINGS RC THALIDOMIDE DOES NOT PERTURB CD2, CD4, CD5, CD8, HLA-DR, OR HLA-A, HLA-B, HLA-C MOLECULES IN-VITRO ON THE MEMBRANES OF CELLS WITH IMMUNE POTENTIAL | 5 | 5 |
1495 | 4 | 22 | 1268 1996 IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY 18(1):59-72 Shannon EJ; Sandoval F Thalidomide can be either agonistic or antagonistic to LPS evoked synthesis of TNF-alpha by mononuclear cells | 21 | 24 |
1496 | 6 | 35 | 1341 1997 IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY 19(3):313-326 Aseffa A; Dietrich MA; Shannon EJ Effect of thalidomide on apoptosis of lymphocytes and neutrophils | 4 | 5 |
1497 | 1 | 4 | 552 1972 INDIAN JOURNAL OF EXPERIMENTAL BIOLOGY 10(4):314-& THOMAS BP; VARIA MR; MEMON GN; ANSARI MM EFFECT OF THALIDOMIDE ON LIVER REGENERATION IN RAT | 1 | 1 |
1498 | 5 | 7 | 553 1972 INDIAN JOURNAL OF EXPERIMENTAL BIOLOGY 10(4):316-& THOMAS BP; VARIA MR; ANSARI MM; MEMON GN LACK OF THALIDOMIDE INDUCED APLASIA IN REGENERATING TAIL OF LIZARD, HEMIDACTYLUS-FLAVIVIRDIS | 0 | 0 |
1499 | 3 | 28 | 623 1976 INDIAN JOURNAL OF EXPERIMENTAL BIOLOGY 14(3):258-262 PALAYOOR T; RAVEENDRAN P; BATRA BK RESPONSES OF PRE-IMPLANTATION MOUSE EMBRYOS TO THALIDOMIDE EXPOSURE INUTERO | 0 | 0 |
1500 | 11 | 43 | 1269 1996 INFLAMMATION 20(2):203-215 Kroger H; Miesel R; Dietrich A; Ohde M; Rajnavolgyi E; Ockenfels H Synergistic effects of thalidomide and poly(ADP-ribose) polymerase inhibition on type II collagen-induced arthritis in mice | 1 | 12 |
Page 5: 1 2 3 4 5 6 7 8 9
Generated by:
HistCite(Vlad).
Version: 2004.09.22